Illinois Appellate Court Upholds $45 Million Talc Verdict Against Johnson & Johnson

Regulation
โดย Simply Wall St·Read original
Summary · why it matters

The Illinois Appellate Court upheld a $45 million talc verdict against Johnson & Johnson, confirming the original jury finding rather than reducing or overturning it. The ruling may influence expectations around ongoing talc litigation and future legal outcomes for the company. Johnson & Johnson shares currently trade at $256.98, with a 7.8% return over the past 30 days and a 23.9% gain year to date. The upheld verdict could lead investors to focus more on the company's talc-related reserves, disclosures, and case management strategies.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Johnson & Johnson
JNJ
▼ NegativeRegulationrelevance

Illinois Appellate Court upheld $45M talc verdict against J&J, increasing legal risk and potential liabilities.